Jaypee Hospital, Noida – India
About Dr. Suhas Singla
Dr. Suhas Singla is a highly experienced Nuclear Medicine specialist with 12–14 years of expertise in diagnostic and therapeutic nuclear medicine. As Associate Director of Nuclear Medicine, he pioneered advanced molecular therapies including 177Lu-PSMA and 177Lu-DOTATATE in Delhi-NCR, combining innovation with rigorous evidence-based cancer imaging and treatment.
- 12–14 years of specialized nuclear medicine and molecular imaging expertise
- MD in Nuclear Medicine from AIIMS, New Delhi (2007–2010)
- Published 29+ papers in national and international peer-reviewed journals
- Pioneer in 177Lu-PSMA and 177Lu-DOTATATE therapy introduction in India
- Fluent in Hindi and English
Qualifications & Credentials
Medical Degrees
- MBBS — Medical college in India
- MD (Doctor of Medicine) in Nuclear Medicine — All India Institute of Medical Sciences (AIIMS), New Delhi, India, 2010
Fellowships & Special Training
- Senior residency in Nuclear Medicine — AIIMS, New Delhi
- Advanced training in diagnostic and therapeutic nuclear medicine
- Specialised training in PET-CT imaging and oncology applications
- Training in targeted radionuclide therapy (177Lu-PSMA, 177Lu-DOTATATE)
- Exposure to international nuclear medicine standards and practices
Certifications & Accreditations
- Medical Council of India Registration
- Society of Nuclear Medicine, India — Active Member
- Society of Nuclear Medicine, USA — Member
Areas of Expertise
Major Conditions Treated
- Oncology imaging (PET-CT, SPECT-CT)
- Prostate cancer (177Lu-PSMA therapy)
- Neuroendocrine tumours (177Lu-DOTATATE therapy)
- Bone metastases and skeletal imaging
- Cardiac nuclear imaging
- Thyroid cancer and thyroid imaging
- Infection and inflammation imaging
Sub-specialties
- Therapeutic Nuclear Medicine: Pioneer in targeted radionuclide therapy including 177Lu-PSMA for advanced prostate cancer — leading nuclear medicine specialist in Noida for international patients seeking advanced cancer therapy.
- Neuroendocrine Tumor (NET) Imaging and Therapy: Specialized in 177Lu-DOTATATE therapy and peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours.
- Oncology PET-CT: Expert in metabolic imaging for cancer staging, restaging, and response assessment.
Advanced Procedures & Treatments
- PET-CT imaging (Oncology, Neurology, Cardiology)
- SPECT-CT imaging and hybrid scanning
- 177Lu-PSMA therapy for advanced prostate cancer
- 177Lu-DOTATATE therapy for neuroendocrine tumours
- Bone pain palliation therapy
- Thyroid imaging and cancer assessment
- Cardiac viability imaging
List of Disease and Treatment for which Dr. Suhas Singla can be consulted
Professional Experience
Current Affiliation
- Associate Director, Department of Nuclear Medicine — Medanta Hospital, Noida (Present)
- Consultant Nuclear Medicine — Max Super Speciality Hospital, Noida (Present)
Past Affiliations
- Nuclear Medicine specialist at various Delhi-NCR hospitals (2010–Present)
- Research and clinical practice at AIIMS, New Delhi
Key Achievements
- 12–14 years of nuclear medicine and oncology imaging expertise
- Pioneer in introducing 177Lu-PSMA and 177Lu-DOTATATE therapies in Delhi-NCR region
- Published 29+ research papers in national and international journals
- High expertise in molecular oncology imaging
- Active participant in nuclear medicine research and innovation
Awards & Recognitions
Professional Memberships
- Society of Nuclear Medicine, India — Active Member
- Society of Nuclear Medicine, USA — Member
- Indian Medical Association (IMA)
Research & Publications
Published Papers (Selected)
- Singla S, et al. 177Lu-PSMA therapy outcomes in advanced prostate cancer: Single center experience. Nuclear Medicine Communications. 2020.
- Singla S, et al. Diagnostic and therapeutic applications of 177Lu-DOTATATE in neuroendocrine tumours. Journal of Nuclear Medicine. 2019.
Ongoing Research & Clinical Interests
- 177Lu-PSMA and targeted radionuclide therapy outcomes
- Neuroendocrine tumor imaging and therapy
- PET-CT advances in cancer staging
- Molecular imaging in oncology
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Nuclear Medicine consultation | ₹1,500 – ₹3,000 | $18 – $36 |
| PET-CT imaging (whole body) | ₹25,000 – ₹40,000 | $300 – $480 |
| SPECT-CT imaging | ₹20,000 – ₹35,000 | $240 – $420 |
| 177Lu-PSMA therapy (per cycle) | ₹3,00,000 – ₹5,00,000 | $3,600 – $6,000 |
| 177Lu-DOTATATE therapy (per cycle) | ₹3,00,000 – ₹4,50,000 | $3,600 – $5,400 |
| Bone pain palliation therapy | ₹1,50,000 – ₹2,50,000 | $1,800 – $3,000 |
| *Costs include imaging and therapeutic agent costs. Final pricing depends on patient weight, imaging protocol, and hospital package. Contact Cancer Rounds for detailed nuclear medicine cost estimate. | ||
Frequently Asked Questions
1. What advanced nuclear medicine technologies does Dr. Suhas use?
Dr. Suhas employs latest PET-CT, SPECT-CT imaging, and pioneering targeted radionuclide therapies including 177Lu-PSMA and 177Lu-DOTATATE. His expertise in molecular imaging enables precise cancer diagnosis, staging, and advanced targeted therapy for international patients.
2. What conditions does Dr. Suhas Singla specialize in treating?
Dr. Suhas specializes in cancer imaging (PET-CT), prostate cancer therapy (177Lu-PSMA), neuroendocrine tumours (177Lu-DOTATATE), bone imaging, and cardiac imaging. International patients seek him for advanced nuclear medicine oncology imaging and therapy in Noida.
3. How do I book an appointment with Dr. Suhas Singla?
Appointments can be booked through Cancer Rounds website or by contacting the international patient concierge. Cancer Rounds will schedule consultations and imaging procedures at Medanta or Max Super Speciality Hospital with priority availability.
4. Can international patients receive nuclear medicine treatment from Dr. Suhas?
Yes. Cancer Rounds provides complete support for international nuclear medicine patients including medical visa letters, hospital coordination, accommodation, airport transfers, and financial counselling for advanced cancer imaging and therapy.
5. What support is available for international nuclear medicine patients?
Cancer Rounds offers language interpretation, virtual pre-treatment consultations with Dr. Suhas, medical record coordination, and complete concierge support throughout your nuclear medicine imaging and therapy procedures.
6. Does Dr. Suhas offer second opinions for nuclear medicine and cancer imaging cases?
Yes. Second opinion consultations for cancer imaging interpretation and treatment planning are available. Dr. Suhas will review your imaging and provide expert guidance on nuclear medicine diagnosis and best treatment options.
Fortis Hospital Noida – Leading Cancer Care Hospital in Delhi NCR - India
Head and Neck Cancer
